These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Propylthiouracil and hepatitis: a case report. Reddy CM J Natl Med Assoc; 1979 Dec; 71(12):1185-6. PubMed ID: 522183 [TBL] [Abstract][Full Text] [Related]
4. Propylthiouracil hypersensitivity with circumstantial evidence for drug-induced reversible sensorineural deafness: a case report. Fong PC; Pun KK; Tai YT; Wang C; Yeung RT Horm Res; 1991; 35(3-4):132-6. PubMed ID: 1806466 [TBL] [Abstract][Full Text] [Related]
5. Hepatotoxicity from propylthiouracil. Westphal SA South Med J; 1994 Sep; 87(9):943-7. PubMed ID: 8091264 [TBL] [Abstract][Full Text] [Related]
6. Propylthiouracil-induced hepatic damage. Weiss M; Hassin D; Bank H Arch Intern Med; 1980 Sep; 140(9):1184-5. PubMed ID: 6893265 [TBL] [Abstract][Full Text] [Related]
7. Propylthiouracil-associated hepatitis. Peter SA J Natl Med Assoc; 1991 Jan; 83(1):75-7. PubMed ID: 1994070 [TBL] [Abstract][Full Text] [Related]
8. Detection of hypersensitivity to drugs by lymphocyte cultures in allergic drug hepatitis [proceedings]. Yamamoto ; Sukeo ; Enomoto ; Mizoguchi T; Yashuhiro Rev Gastroenterol Mex; 1975; 40(4):218-9. PubMed ID: 801199 [No Abstract] [Full Text] [Related]
9. [Chemically induced disorders of the liver associated with jaundice]. Bliuger AF; Akinfova TA; Kartashova OIa; Maksimova LA Ter Arkh; 1972 Oct; 44(10):72-5. PubMed ID: 4659391 [No Abstract] [Full Text] [Related]
10. Fulminant hepatic failure associated with propylthiouracil: a case report with treatment emphasis on the use of plasmapheresis. Aydemir S; Ustundag Y; Bayraktaroglu T; Tekin IO; Peksoy I; Unal AU J Clin Apher; 2005 Dec; 20(4):235-8. PubMed ID: 16206173 [TBL] [Abstract][Full Text] [Related]
11. Propylthiouracil hepatotoxicity: two pediatric cases and review of the literature. Jonas MM; Eidson MS J Pediatr Gastroenterol Nutr; 1988; 7(5):776-9. PubMed ID: 3054039 [TBL] [Abstract][Full Text] [Related]
12. Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil. Mihas AA; Holley P; Koff RS; Hirschowitz BI Gastroenterology; 1976 May; 70(5 PT.1):770-4. PubMed ID: 1261772 [TBL] [Abstract][Full Text] [Related]
13. Propylthiouracil and hepatitis. Two cases and a review of the literature. Hanson JS Arch Intern Med; 1984 May; 144(5):994-6. PubMed ID: 6608933 [TBL] [Abstract][Full Text] [Related]
14. Immunological investigation in hepatic drug reactions. Maria VA; Victorino RM Clin Exp Allergy; 1998 Sep; 28 Suppl 4():71-7. PubMed ID: 9761038 [No Abstract] [Full Text] [Related]
15. Cell-mediated immunity in halothane hypersensitivity. Doniach D N Engl J Med; 1970 Aug; 283(6):315-6. PubMed ID: 5427061 [No Abstract] [Full Text] [Related]
16. Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? Williams KV; Nayak S; Becker D; Reyes J; Burmeister LA J Clin Endocrinol Metab; 1997 Jun; 82(6):1727-33. PubMed ID: 9177371 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. Paronetto F; Popper H N Engl J Med; 1970 Aug; 283(6):277-80. PubMed ID: 5448331 [No Abstract] [Full Text] [Related]
18. Characterization of drug-specific lymphocyte responses in a patient with drug-induced liver injury. El-Ghaiesh S; Sanderson JP; Farrell J; Lavergne SN; Syn WK; Pirmohamed M; Park BK; Naisbitt DJ J Allergy Clin Immunol; 2011 Sep; 128(3):680-3. PubMed ID: 21596425 [No Abstract] [Full Text] [Related]